Literature DB >> 9826724

Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.

H Zhu1, J P Cong, G Mamtora, T Gingeras, T Shenk.   

Abstract

Mechanistic insights to viral replication and pathogenesis generally have come from the analysis of viral gene products, either by studying their biochemical activities and interactions individually or by creating mutant viruses and analyzing their phenotype. Now it is possible to identify and catalog the host cell genes whose mRNA levels change in response to a pathogen. We have used DNA array technology to monitor the level of approximately 6,600 human mRNAs in uninfected as compared with human cytomegalovirus-infected cells. The level of 258 mRNAs changed by a factor of 4 or more before the onset of viral DNA replication. Several of these mRNAs encode gene products that might play key roles in virus-induced pathogenesis, identifying them as intriguing targets for further study.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826724      PMCID: PMC24397          DOI: 10.1073/pnas.95.24.14470

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells.

Authors:  T Shibutani; T M Johnson; Z X Yu; V J Ferrans; J Moss; S E Epstein
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Multiplexed biochemical assays with biological chips.

Authors:  S P Fodor; R P Rava; X C Huang; A C Pease; C P Holmes; C L Adams
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

3.  Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus.

Authors:  G V Quinnan; M Delery; A H Rook; W R Frederick; J S Epstein; J F Manischewitz; L Jackson; K M Ramsey; K Mittal; S A Plotkin
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

4.  Light-generated oligonucleotide arrays for rapid DNA sequence analysis.

Authors:  A C Pease; D Solas; E J Sullivan; M T Cronin; C P Holmes; S P Fodor
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

5.  Clinical anophthalmia associated with congenital cytomegalovirus infection.

Authors:  R W McCarthy; L D Frenkel; C R Kollarits; M P Keys
Journal:  Am J Ophthalmol       Date:  1980-10       Impact factor: 5.258

6.  Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene.

Authors:  M Tassabehji; V E Newton; A P Read
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

7.  Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences.

Authors:  E Steingrímsson; K J Moore; M L Lamoreux; A R Ferré-D'Amaré; S K Burley; D C Zimring; L C Skow; C A Hodgkinson; H Arnheiter; N G Copeland
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

8.  trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus.

Authors:  M C Pizzorno; P O'Hare; L Sha; R L LaFemina; G S Hayward
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus.

Authors:  B C Rodgers; D M Scott; J Mundin; J G Sissons
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo.

Authors:  A J Chapman; H E Farrell; J A Thomas; J M Papadimitriou; M J Garlepp; A A Scalzo; G R Shellam
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

View more
  167 in total

1.  Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.

Authors:  R G Jenner; M M Albà; C Boshoff; P Kellam
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Herpes simplex virus triggers and then disarms a host antiviral response.

Authors:  K L Mossman; P F Macgregor; J J Rozmus; A B Goryachev; A M Edwards; J R Smiley
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Normalization strategies for cDNA microarrays.

Authors:  J Schuchhardt; D Beule; A Malik; E Wolski; H Eickhoff; H Lehrach; H Herzel
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

Review 4.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

5.  A rapid genetic screening system for identifying gene-specific suppression constructs for use in human cells.

Authors:  G M Arndt; M Patrikakis; D Atkins
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

6.  Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR.

Authors:  M S Rajeevan; S D Vernon; N Taysavang; E R Unger
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

7.  The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies.

Authors:  C E Belcher; J Drenkow; B Kehoe; T R Gingeras; N McNamara; H Lemjabbar; C Basbaum; D A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

8.  Virus self-improvement through inflammation: no pain, no gain.

Authors:  Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

9.  Gammaherpesvirus lytic gene expression as characterized by DNA array.

Authors:  Joo Wook Ahn; Kenneth L Powell; Paul Kellam; Dagmar G Alber
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.